KDM1A and cancer: In order to evaluate the potential of twenty distinct compounds as therapeutic agents that target lysine-specific demethylase 1 (LSD1) and topoisomerase II (topo II) in the treatment of cancer and infectious diseases, we conducted a complete computer analysis of each drug in this study.